nach oben

Virchows Archiv

Erschienen in:

01.04.2011 | Review and Perspective

What is expected from the pathologist in the diagnosis of viral hepatitis?

verfasst von: Helmut Denk

Erschienen in: Virchows Archiv | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

The clinician expects from the pathologist a clinically relevant diagnosis on the basis of liver biopsy interpretation. Today, a liver biopsy, as invasive procedure, is only justified when a significant benefit for the patient can be expected particularly with respect to the clinical management. Consequently, liver biopsy is usually not required in uncomplicated acute viral hepatitis. It is, however, an important diagnostic tool in chronic hepatitis and in transplanted liver to confirm the clinical diagnosis and to assess stage and grade of necroinflammation, treatment efficiency, and concurrent diseases. The diagnosis of liver disease is based on teamwork between clinician and pathologist. Evaluation of the biopsy in the clinical context requires clinical information and appropriate size and handling of the biopsy specimen. Aim of this review is the discussion of morphologic features of acute and chronic viral hepatitis with regard to their clinical relevance.

Desmet VJ (2003) Liver tissue examination. J Hepatol 39:543–549

Rockey DC, Caldwell SH, Goodman ZD et al (2009) Liver biopsy. Hepatology 49:1017–1044PubMed

Dienstag JL (2002) The role of liver biopsy in chronic hepatitis C. Hepatology 36:152–160

Lefkowitch JH (2007) Liver biopsy assessment in chronic hepatitis. Arch Med Res 38:634–643PubMed

Gebo KA, Herlong F, Torbenson MS et al (2002) Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 36:161–172

Brunt EM (2000) Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 31:241–246PubMed

Ishak KG (2000) Pathologic features of chronic hepatitis. A review and update. Am J Clin Pathol 113:40–55PubMed

Scheuer PJ, Lefkowitch JH (2005) Liver biopsy interpretation, 7th edn. WB Saunders, New York

Huang SN, Chen TC, Tsai SL et al (1997) Histopathology and pathobiology of hepatotropic virus-induced liver injury. J Gastroenterol Hepatol 12(Suppl):195–217

10.

Ichai P, Samuel D (2008) Etiology and prognosis of fulminant hepatitis in adults. Liver Transplant 14:67–79

11.

Boyer JL, Klatskin G (1970) Pattern of necrosis in acute viral hepatitis. N Engl J Med 283:1063–1071PubMed

12.

Theise ND, Bodenheiner HC Jr, Ferrell LD (2007) Acute and chronic viral hepatitis. In: Burt AD, Portmann BC, Ferrell LD (eds) MacSween's pathology of the liver. 5th edu. Churchill Livingstone, Philadelphia pp 399–441

13.

Vyberg M (1993) The hepatitis-associated bile duct lesion. Liver 13:289–301PubMed

14.

Kobayashi K, Hashimoto E, Ludwig J (1993) Liver biopsy features of acute hepatitis C compared with hepatitis A, B, and non-A, non-B, non-C. Liver 13:69–73PubMed

15.

Hoofnagle JH (2002) Course and outcome of hepatitis C. Hepatology 36:21–29

16.

Missiha SB, Ostrowski M, Heathcote EJ (2008) Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors. Gastroenterology 134:1699–1714PubMed

17.

Gordon FD, Pomfret EA, Pomposelli JJ et al (2004) Severe steatosis as the initial histologic manifestation of recurrent hepatitis C genotype 3. Hum Pathol 35:636–63848PubMed

18.

Karayiannis P (1998) Hepatitis D virus. Rev Med Virol 8:13–24PubMed

19.

Lefkowitch JH, Goldstein H, Yatto R et al (1987) Cytopathic liver injury in acute delta virus hepatitis. Gastroenterology 92:1262–1266PubMed

20.

Benjaminov FS, Heathcote J (2004) Liver disease in pregnancy. Am J Gastroenterol 99:2479–2488PubMed

21.

Navaneethan U, Mohajer MA, Shata MT (2008) Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int 28:1190–1199PubMed

22.

Kamar N, Selves J, Mansury JM et al (2008) Hepatitis E: does it cause chronic hepatitis? Hepatology 48:1328–1330

23.

Hübscher SG (1998) Histological grading and staging in chronic hepatitis: clinical applications and problems. J Hepatol 29:1015–1022PubMed

24.

Dries V, Odenthal M, Schirmacher P et al (2001) Liver biopsy in chronic hepatitis C. Histopathology, molecular diagnostic analysis, and implications for therapeutic management. Pathologe 22:362–368PubMed

25.

Roskams T, Libbrecht L, Desmet VJ (2003) Progenitor cells in diseased human liver. Semin Liver Dis 23:385–396PubMed

26.

Liaw YF, Yang SS, Chen TJ et al (1985) Acute exacerbation in hepatitis B e antigen positive chronic type B hepatitis. J Hepatol 1:227–233PubMed

27.

Koukoulis GK (2001) Chronic hepatitis C: grading, staging, and searching for reliable predictors of outcome. Hum Pathol 32:899–903PubMed

28.

Thein HH, Yi Q, Dore GJ et al (2008) Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology 48:418–431PubMed

29.

Poynard T, Ratziu V, Charlotte F et al (2001) Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 34:730–739PubMed

30.

Goodman ZD (2007) Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 47:598–607PubMed

31.

Alonso-Marti C, Moreno A, Barat A et al (1990) Co-existence of hepatocyte ground-glass inclusions from several causes. Histopathol 16:304–307

32.

Naoumov NV, Eddleston AL (1994) Host immune response and variations in the virus genome: pathogenesis of liver damage caused by hepatitis B virus. Gut 35:1013–1017PubMed

33.

Baumert TF, Thimme R, von Weizsäcker F (2007) Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13:82–90

34.

Naoumov NV, Schneider R, Grötzinger T et al (1992) Precore mutant hepatitis B virus infection and liver disease. Gastroenterology 102:538–543PubMed

35.

Blum HE, Moradpour D, Weizsäcker F et al (1997) Hepatitis-B-Virusmutanten—Klinische Bedeutung. Z Gastroenterol 35:347–355PubMed

36.

Park YN, Han KH, Kim KS et al (1999) Cytoplasmic expression of hepatitis B core antigen in chronic hepatitis B virus infection: role of precore stop mutants. Liver 19:199–205PubMed

37.

Lok ASF, McMahon BJ (2001) Chronic hepatitis B. Hepatology 34:1225–1241PubMed

38.

Chen TJ, Liaw YF (1988) The prognostic significance of bridging hepatic necrosis in chronic type B hepatitis: a histopathologic study. Liver 8:10–16PubMed

39.

Cooksley WGE, Bradbear RA, Robinson W et al (1986) The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology 6:345–348PubMed

40.

Villari D, Raimondo G, Brancatelli S et al (1991) Histological features in liver biopsy specimens of patients with acute reactivation of chronic type B hepatitis. Histopathol 18:73–77

41.

Harada K, Mihato H, Hiramatsu K et al (1998) Epithelioid cell granulomas in chronic hepatitis C: immunohistochemical character and histologic marker of favourable response to interferon-α therapy. Histopathol 33:216–221

42.

Mihm S, Fayyazi A, Hartmann H et al (1997) Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology 25:735–739PubMed

43.

Rubbia-Brandt L, Leandro G, Spahr L (2001) Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3. Histopathology 39:119–124PubMed

44.

Younossi ZM, McCullough AJ (2009) Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response. Liver Int 29:3–12PubMed

45.

Bedossa P, Moucari R, Chelbi E et al (2007) Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study. Hepatology 46:380–387PubMed

46.

Serfaty L, Capeau J (2009) Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data. Liver Int 29:13–25PubMed

47.

Negro F, Sanyal AJ (2009) Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data. Liver Int 29:26–37PubMed

48.

Kumar D, Farrell GC, Fung C et al (2002) Hepatitis C virus genotype 3 is cytopathic to hepatocytes: reversal of hepatic steatosis after sustained therapeutic response. Hepatology 36:1266–1272PubMed

49.

Korenaga M, Wang T, Li Y et al (2005) Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 280:37481–37488PubMed

50.

Sanyal AJ (2005) Review article: non-alcoholic fatty liver disease and hepatitis C—risk factors and clinical implications. Aliment Pharmacol Ther 22(Suppl 2):48–51PubMed

51.

Fartoux L, Charzouillères O, Wendum D et al (2005) Impact of steatosis on progression of fibrosis in patients with mild hepatitis C. Hepatology 41:82–87PubMed

52.

Ohata K, Hamasaki K, Toriyama K et al (2003) Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 97:3036–3043PubMed

53.

Bruno S, Silini E, Crosignani A et al (1997) Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 25:754–758PubMed

54.

Moriya K, Fujie H, Shintani Y et al (1998) The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4(9):1065–1067PubMed

55.

Lai MM (2002) Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroenterology 122(2):568–571PubMed

56.

Haque S, Chandra B, Gerber MA et al (1996) Iron overload in patients with chronic hepatitis C: a clinicopathologic study. Hum Pathol 27:1277–1281PubMed

57.

Desai TK, Jamil LH, Balasubramaniam M et al (2008) Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a metaanalysis of six prospective randomized controlled trials. Dig Dis Sci 53:815–822PubMed

58.

Miura K, Taura K, Kodama Y et al (2008) Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 48:1420–1429PubMed

59.

Chen DS (1993) Natural history of chronic hepatitis B virus infection: new light on an old story. J Gastroenterol Hepatol 8:470–475PubMed

60.

Naoumov NV, Portmann BC, Tedder RS et al (1990) Detection of hepatitis B virus antigens in liver tissue. A relation to viral replication and histology in chronic hepatitis B infection. Gastroenterology 99(4):1248–1253PubMed

61.

Chu CM, Liaw YF (1995) Membrane staining for hepatitis B surface antigen on hepatocytes: a sensitive and specific marker of active viral replication in hepatitis B. J Clin Pathol 48:470–473PubMed

62.

Chu CM, Liaw YF (1987) Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Gastroenterology 92:220–225PubMed

63.

Davies SE, Portmann BC, O’Grady JG et al (1991) Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 13:150–157PubMed

64.

Marinos G, Rossol S, Carucci P et al (2000) Immunopathogenesis of hepatitis B recurrence after liver transplantation. Transplantation 69(4):559–568PubMed

65.

Kawai K, Horiike N, Michitaka K et al (2003) The effects of hepatitis B virus core promoter mutations on hepatitis B core antigen distribution in hepatocytes as detected by laser-assisted microdissection. J Hepatol 38:635–641PubMed

66.

Fujiwara K, Tanaka Y, Paulon E et al (2005) Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype E. J Virol 79:14404–14410PubMed

67.

Shiha GE, Khaled RZ, Abdulla AF et al (2005) Immunohistochemical identification of HCV target antigen in paraffin-embedded liver tissue: reproducibility and staining patterns. Liver Internat 25:254–260

68.

Guerrero RB, Batts KP, Brandhagen DJ et al (1997) Effects of formalin fixation and prolonged block storage on detection of hepatitis C virus RNA in liver tissue. Diagn Mol Pathol 6:277–28149PubMed

69.

Bean P (2002) Latest discoveries on the infection and coinfection with heptatitis D virus. Am Clin Lab 21:25–27PubMed

70.

Guido M, Swan NT, Fattovich G et al (1999) Intrahepatic expression of hepatitis B virus antigens: effect of hepatitis C virus infection. Mod Pathol 12:599–603PubMed

71.

Blackard JT, Sherman KE (2008) HCV/HIV co-infection: time to re-evaluate the role of HIV in the liver. J Viral Hepat 15:323–330PubMed

72.

Regev A, Berho M, Jeffers LJ et al (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97:2614–2618PubMed

73.

Demetris AJ, Ruppert K (2003) Pathologist's perspective on liver needle biopsy size. J Hepatol 39:275–277PubMed

74.

Colloredo G, Guido M, Sonzogni A et al (2003) Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 39:275–277

75.

Shiano TD, Azeem S, Bodia CA et al (2005) Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C. Clin Gastroenterol Hepatol 3:930–935

76.

Skripenova S, Trainer T, Krawitt E et al (2007) Variability of grade and stage in simultaneous paired liver biopsies in hepatitis C. J Clin Pathol 60:321–324PubMed

77.

Scheuer PJ (2003) Liver biopsy size matters in chronic hepatitis: bigger is better. Hepatology 38:1356–1358PubMed

78.

Shiano TD, Azeem S, Bodian CA et al (2005) Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C. Clin Gastroenterol Hepatol 3:930–935

79.

Ishak K, Baptista A, Bianchi L et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699PubMed

80.

Bedossa P, Dargere D, Paradis V (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38:1449–1457PubMed

81.

Bedossa P, and The METAVIR cooperative study group (1996) An algorithm for the grading of activity in chronic hepatitis. Hepatology 24:289–293PubMed

82.

Schirmacher P, Fleig WE, Tannapfel A et al (2004) Bioptische Diagnostik der chronischen Hepatitis. Pathologe 25:338–348

83.

Goodman ZD, Becker RL, Pockros PJ et al (2007) Progression of fibrosis in chronic hepatitis C: evaluation by morphometric image analysis. Hepatology 45:886–894PubMed

84.

Scheuer P (1997) Chronic hepatitis: what is activity and how should it be assessed. Histopathol 30:103–105

85.

Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19:1409–1417PubMed

86.

Zhu R, Huang H, Zhang H et al (2006) Prognostic analysis in chronic hepatitis B patients: a retrospective study of 216 cases about Scheuer scores, in situ expression of viral antigens and tissue hepatitis B virus DNA levels. Liver Int 26:82–89PubMed

87.

Knodell RG, Ishak KG, Black WC et al (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435PubMed

88.

METAVIR cooperative group (1994) Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C. Hepatology 20:15–20

89.

Goodman ZD, Ishak KG, Sesterhenn IA (1986) Herpes simplex hepatitis in apparently immunocompetent adults. Am J Clin 85:694–699

90.

Jaques SM, Qureshi F (1992) Herpes simplex virus hepatitis in pregnancy: a clinicopathologic study of three cases. Hum Pathol 23:183–187

91.

Markin RS (1994) Manifestations of Epstein–Barr-virus in inflammatory diseases of the liver and liver allografts: an in situ hybridization study. Hepatology 20:899–907

92.

Seehofer D, Rayes N, Tullius SG et al (2002) CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow up. Liver Transplant 8:1138–1146

93.

MacDonald GA, Greenson JK, DelBuono EA et al (1997) Mini-microabscess syndrome in liver transplant patients. Hepatology 26:192–197PubMed

94.

Theise ND, Conn M, Thung SN (1993) Localization of cytomegalovirus antigens in liver allografts over time. Hum Pathol 24:103–108PubMed

95.

Carmichael GP Jr, Zahradnik JM, Moyer GH et al (1979) Adenovirus hepatitis in an immunosuppressed adult patient. Am J Clin Pathol 71:352–355PubMed

96.

Huerre MR, Lan NT, Marianneau P et al (2001) Liver histopathology and biological correlates in five cases of fatal dengue fever in Vietnamese children. Virchow’s Arch 438:107–114

97.

Vieira WT, Gayotto LC, de Lima CP et al (1983) Histopathology of the human liver in yellow fever with special emphasis on the diagnostic role of the Councilman body. Histopathology 7:195–208PubMed

98.

Harrison RF, Davies MH, Goldin RD et al (1993) Recurrent hepatitis B in liver allografts: a distinctive form of rapidly developing cirrhosis. Histopathology 23:21–28PubMed

99.

Lau JY, Bain VG, Davies SE et al (1992) High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 102:956–962PubMed

100.

Gaglio P, Singh S, Degertekin B et al (2008) Impact of the hepatitis B virus genotype on pre- and post-liver transplantation outcomes. Liver Transplant 14:1420–1427

101.

Demetris AJ, Eghtesad B, Marcos A et al (2009) Evolution of hepatitis C virus in liver allografts. Liver Transplant 15:35–41

102.

Guerrero RB, Batts KB, Burgart LJ et al (2000) Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study. Mod Pathol 13:229–237PubMed

103.

Saxena R, Crawford JM, Navarro VJ et al (2002) Utilization of acidophil bodies in the diagnosis of recurrent hepatitis C infection after orthotopic liver transplantation. Mod Pathol 15:897–903PubMed

104.

Ercolani G, Grazi GL, Ravaioli M et al (2006) Histological recurrent hepatitis C after liver transplantation: outcome and role of retransplantation. Liver Transplant 12:1104–1111

105.

Hübscher SG, Portmann BC (2007) Transplantation pathology. In: Burt AD, Portmann BC, Ferrell LD (eds) MacSween’s pathology of the liver. 5th edu. Churchill Livingstone, Philadelphia pp 815–879

106.

Schluger LK, Sheiner PA, Thung SN et al (1996) Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 23:971–976PubMed

107.

David E, Rahier J, Pucci A et al (1993) Recurrence of hepatitis D (delta) in liver transplants: histopathological aspects. Gastroenterology 104:1122–1128PubMed

108.

Libbrecht L, Roskams T (2006) Molecular diagnostic approach to liver tissue as an ancillary tool for liver histopathology. Semin Liver Dis 26:328–336PubMed

109.

Geller SA, Pitman MB, Nichols WS (2007) Cellular and molecular diagnostic techniques. In: Burt AD, Portmann BC, Ferrell LD (eds) MacSween's pathology of the liver, 5th edn. Churchill Livingstone, Philadelphia, pp 119–146

Titel: What is expected from the pathologist in the diagnosis of viral hepatitis?
verfasst von: Helmut Denk
Publikationsdatum: 01.04.2011
Verlag: Springer-Verlag
Erschienen in: Virchows Archiv / Ausgabe 4/2011
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-011-1057-2

Springer Medizin

What is expected from the pathologist in the diagnosis of viral hepatitis?

Abstract

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2011

Precursor lesions of early onset pancreatic cancer

Diffuse lymphangiomatous hyperplasia of the spleen with hyaline bodies. A pseudotumoral proliferation arising from the lymphatic vessels of the periarteriolar lymphatic sheath

Gene expression profiling of human hepatoblastoma using archived formalin-fixed and paraffin-embedded tissues

Differentially expressed genes in giant cell tumor of bone

Combined small-cell carcinoma of the lung with quadripartite differentiation of epithelial, neuroendocrine, skeletal muscle, and myofibroblastic type

Inflammation in gastric adenocarcinoma of the cardia: how do EBV infection, Her2 amplification and cancer progression influence tumor-infiltrating lymphocytes?

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie